Yao Li

Yao Li

Jenner & Block

Contact
View Bio
RSS

Latest Publications

Share:

Client Alert: What’s Next for Mifepristone?

Medication abortions using mifepristone and misoprostol now account for more than half of all abortions performed in the United States today. In the post-Dobbs era, medication abortion is critical to reproductive rights...more

4/12/2023  /  Abortion , Federal Food Drug and Cosmetic Act (FFDCA) , Food and Drug Administration (FDA) , Prescription Drugs , Reproductive Healthcare Issues

Client Alert: Standing Up for Diversity: How the Federal Government and States Are Fighting Back Against Anti-DEI Initiatives

Since we published our prior client alert on state efforts to dismantle diversity, equity, and inclusion (DEI) initiatives, state-level anti-DEI efforts have gained significant momentum. Several new anti-DEI legislative...more

3/29/2023  /  Biden Administration , Children's Health Insurance Program (CHIP) , Department of Labor (DOL) , Diversity and Inclusion Standards (D&I) , Equity , Executive Orders

Client Alert: Assistant Attorney General Announces Changes to DOJ’s Corporate Enforcement Policy

On January 17, 2023, Assistant Attorney General (AAG) Kenneth Polite, Jr., delivered a speech announcing several important revisions to the Department of Justice (DOJ) Criminal Division’s Corporate Enforcement Policy (CEP)...more

1/23/2023  /  Corporate Crimes , Corporate Misconduct , Department of Justice (DOJ) , Enforcement , FCPA Corporate Enforcement Policy (CEP) , Federal Sentencing Guidelines , Foreign Corrupt Practices Act (FCPA) , Investigations , Self-Disclosure Requirements
3 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide